Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:INOV

Inovalon (INOV) Stock Price, News & Analysis

Inovalon logo

About Inovalon Stock (NASDAQ:INOV)

Advanced Chart

Key Stats

Today's Range
$33.00
$33.07
50-Day Range
$40.66
$41.06
52-Week Range
$17.56
$41.06
Volume
245 shs
Average Volume
720,587 shs
Market Capitalization
$5.13 billion
P/E Ratio
97.26
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive INOV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Inovalon and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

INOV Stock News Headlines

Trump's Law S.1582: $21T Dollar Revolution Coming
Do you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. If you do…tc pixel
See More Headlines

INOV Stock Analysis - Frequently Asked Questions

Inovalon Holdings, Inc. (NASDAQ:INOV) announced its quarterly earnings data on Wednesday, July, 28th. The technology company reported $0.19 EPS for the quarter, topping analysts' consensus estimates of $0.17 by $0.02. The technology company earned $190.44 million during the quarter, compared to the consensus estimate of $183.89 million. Inovalon had a trailing twelve-month return on equity of 10.97% and a net margin of 6.73%.

Inovalon (INOV) raised $500 million in an IPO on Thursday, February 12th 2015. The company issued 22,200,000 shares at a price of $21.00-$24.00 per share. Goldman Sachs, Morgan Stanley, Citigroup, BofA Merrill Lynch and UBS Investment Bank served as the underwriters for the IPO and Baird, Piper Jaffray, Wells Fargo Securities and William Blair were co-managers.

Inovalon's top institutional investors include Americana Partners LLC (0.04%), Steward Partners Investment Advisory LLC (0.02%), Luminist Capital LLC (0.02%) and Maltin Wealth Management Inc. (0.02%).
View institutional ownership trends
.

Based on aggregate information from My MarketBeat watchlists, some other companies that Inovalon investors own include NVIDIA (NVDA), Pfizer (PFE), Advanced Micro Devices (AMD), Moderna (MRNA), Meta Platforms (META) and PayPal (PYPL).

Company Calendar

Last Earnings
7/28/2021
Today
9/10/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Data Processing & Preparation
Sub-Industry
N/A
Current Symbol
NASDAQ:INOV
CIK
1619954
Employees
1,836
Year Founded
1998

Profitability

EPS (Trailing Twelve Months)
$0.34
Trailing P/E Ratio
97.26
Forward P/E Ratio
55.11
P/E Growth
2.99
Net Income
$22.58 million
Net Margins
6.73%
Pretax Margin
5.86%
Return on Equity
10.97%
Return on Assets
4.10%

Debt

Debt-to-Equity Ratio
1.17
Current Ratio
2.40
Quick Ratio
2.40

Sales & Book Value

Annual Sales
$667.52 million
Price / Sales
7.69
Cash Flow
$0.99 per share
Price / Cash Flow
33.35
Book Value
$4.94 per share
Price / Book
6.69

Miscellaneous

Outstanding Shares
155,246,000
Free Float
78,011,000
Market Cap
$5.13 billion
Optionable
No Data
Beta
0.53

Social Links

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

This page (NASDAQ:INOV) was last updated on 9/10/2025 by MarketBeat.com Staff
From Our Partners